X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE NOVARTIS SUVEN LIFE/
NOVARTIS
 
P/E (TTM) x 16.3 342.6 4.8% View Chart
P/BV x 3.0 16.9 17.9% View Chart
Dividend Yield % 1.2 1.7 72.4%  

Financials

 SUVEN LIFE   NOVARTIS
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
NOVARTIS
Mar-16
SUVEN LIFE/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs339982 34.5%   
Low Rs144556 26.0%   
Sales per share (Unadj.) Rs39.2252.9 15.5%  
Earnings per share (Unadj.) Rs7.562.1 12.0%  
Cash flow per share (Unadj.) Rs8.863.3 13.9%  
Dividends per share (Unadj.) Rs2.0010.00 20.0%  
Dividend yield (eoy) %0.81.3 63.7%  
Book value per share (Unadj.) Rs49.0363.6 13.5%  
Shares outstanding (eoy) m127.2831.96 398.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.23.0 202.3%   
Avg P/E ratio x32.412.4 261.5%  
P/CF ratio (eoy) x27.512.2 226.4%  
Price / Book Value ratio x4.92.1 233.0%  
Dividend payout %26.816.1 166.6%   
Avg Mkt Cap Rs m30,73224,580 125.0%   
No. of employees `0001.00.8 126.9%   
Total wages/salary Rs m4161,801 23.1%   
Avg. sales/employee Rs Th5,236.110,748.9 48.7%   
Avg. wages/employee Rs Th436.52,395.2 18.2%   
Avg. net profit/employee Rs Th995.52,641.1 37.7%   
INCOME DATA
Net Sales Rs m4,9958,083 61.8%  
Other income Rs m194829 23.3%   
Total revenues Rs m5,1898,913 58.2%   
Gross profit Rs m1,233234 526.3%  
Depreciation Rs m16737 455.6%   
Interest Rs m542 3,011.1%   
Profit before tax Rs m1,2051,025 117.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m017 0.0%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m255752 33.9%   
Profit after tax Rs m9501,986 47.8%  
Gross profit margin %24.72.9 851.7%  
Effective tax rate %21.273.4 28.9%   
Net profit margin %19.024.6 77.4%  
BALANCE SHEET DATA
Current assets Rs m4,98612,678 39.3%   
Current liabilities Rs m1,0422,433 42.8%   
Net working cap to sales %79.0126.7 62.3%  
Current ratio x4.85.2 91.8%  
Inventory Days Days6133 186.5%  
Debtors Days Days3922 174.0%  
Net fixed assets Rs m3,12669 4,516.6%   
Share capital Rs m127160 79.7%   
"Free" reserves Rs m3,71711,460 32.4%   
Net worth Rs m6,23611,621 53.7%   
Long term debt Rs m4320-   
Total assets Rs m8,07914,400 56.1%  
Interest coverage x23.2570.5 4.1%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.60.6 110.1%   
Return on assets %12.413.8 90.0%  
Return on equity %15.217.1 89.1%  
Return on capital %18.923.6 80.1%  
Exports to sales %87.50.7 11,748.0%   
Imports to sales %12.218.6 65.8%   
Exports (fob) Rs m4,37160 7,260.0%   
Imports (cif) Rs m6111,503 40.6%   
Fx inflow Rs m4,666186 2,504.8%   
Fx outflow Rs m9421,821 51.7%   
Net fx Rs m3,724-1,635 -227.9%   
CASH FLOW
From Operations Rs m9222,531 36.4%  
From Investments Rs m-619-8,270 7.5%  
From Financial Activity Rs m-698-386 181.1%  
Net Cashflow Rs m-396-6,125 6.5%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 2.0 -  
FIIs % 0.0 1.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 21.5 169.8%  
Shareholders   37,287 41,647 89.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   VENUS REMEDIES  SHASUN PHARMA  PFIZER  FDC LTD.  ORCHID PHARMA LTD  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 22, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS